Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Areej El‐Jawahri et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate CancerEmmanuel S. Antonarakis, Michael A. Carducci, Elisabeth I. Heath et al.|The Oncologist|2013Cited by 178
<i>TKTL1</i> Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α StabilizationWenyue Sun, Joseph A. Califano, Yan Liu et al.|Clinical Cancer Research|2010Cited by 116
A phase 1 trial of the oral DNA methyltransferase inhibitor CC‐486 and the histone deacetylase inhibitor romidepsin in advanced solid tumorsStéphanie Gaillard, Nilofer S. Azad, Marianna Zahurak et al.|Cancer|2019Cited by 56
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13